Contact

• workRoom 2123 Queens Medical Centre
  Queen's Medical Centre
  Nottingham
  NG7 2UH
  UK
• Brittany.Hare@nottingham.ac.uk
• ORCID ID: 0000-0001-5146-4911

Biography

Brittany Dutton is a research associate in the Division of Primary Care. Her current research is identifying and managing patients with an increased high of the genetically inherited condition Familial Hypercholesterolaemia (FH) in primary care (FAMCAT Study; NIHR SPCR funded). She is also involved with a long term follow up observational study (ECLIPSE Study: NIHR HTA funded) which is exploring women's experience of heavy menstrual bleeding through qualitative and quantitative methodologies.

Expertise Summary

Main areas of expertise are regarding the pre-trial set up, management of active trials or studies - ranging from ethical approvals and governance to database management and monitoring and end of study close down. She is very interested in genetics research but her personal interest and background is within psychology and mental health.

Recent Publications

• LEE, S.I., QURESHI, N., DUTTON, B., KAI, J. and WENG, S., 2020. Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care Journal of Community Genetics. Published Online First: 22 January 2020,
• QURESHI, N., DUTTON, B., WENG, S., SHEEHAN, C., CHORLEY, W., ROBERTSON, J.F.R., KENDRICK, D. and KAI, J., 2020. Improving primary care identification of familial breast cancer risk using proactive invitation and decision support Familial Cancer. First Published Online: 11 June 2020,
• LEE, S.I., CURTIS, H., QURESHI, S., DUTTON, B. and QURESHI, N., 2020. Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England Journal of Community Genetics. Published Online First: 28 October 2020,
• LEE, S.I., PATEL, M., DUTTON, B., WENG, S., LUVETA, J. and QURESHI, N., 2019. Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review Journal of Community Genetics. Published Online First: 6 May 2019

• View all publications

• LEE, S.I., QURESHI, N., DUTTON, B., KAI, J. and WENG, S., 2020. Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care Journal of Community Genetics. Published Online First: 22 January 2020,
• QURESHI, N., DUTTON, B., WENG, S., SHEEHAN, C., CHORLEY, W., ROBERTSON, J.F.R., KENDRICK, D. and KAI, J., 2020. Improving primary care identification of familial breast cancer risk using proactive invitation and decision support Familial Cancer. First Published Online: 11 June 2020,
• LEE, S.I., CURTIS, H., QURESHI, S., DUTTON, B. and QURESHI, N., 2020. Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England Journal of Community Genetics. Published Online First: 28 October 2020,
• LEE, S.I., PATEL, M., DUTTON, B., WENG, S., LUVETA, J. and QURESHI, N., 2019. Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review Journal of Community Genetics. Published Online First: 6 May 2019
• CARDOSO, D., WAKEHAM, J., SHAW, P.A., DUTTON, B. and WILDMAN, L., 2017. Chlorpromazine versus thiothixene for people with schizophrenia Cochrane Database of Systematic Reviews. No.: CD012790. DOI: 10.1002/14651858.CD012790.